Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Mitazalimab (Anti-TNFRSF5 / CD40) For research use only.
Not for use in humans.

Mitazalimab (Anti-TNFRSF5 / CD40)

Synonyms: ADC-1013; JNJ-64457107

Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.

Mitazalimab (Anti-TNFRSF5 / CD40)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.

Product Details

CAS No. 2055640-86-1
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) supplier | purchase Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) cost | Mitazalimab (Anti-TNFRSF5 / CD40) manufacturer | order Mitazalimab (Anti-TNFRSF5 / CD40) | Mitazalimab (Anti-TNFRSF5 / CD40) distributor